PET Probe May Aid in Cancer Detection and Treatment

"New PET Probe Developed to Aid in Cancer Detection and Treatment"

"Researchers at the UCLA Jonsson Comprehensive Cancer Center spent seven years trying to better identify and understand the role of the deoxycytidine kinase (dCK) enzyme in cancer mutations through PET imaging- and findings published March 28 in the journal Proceedings of the National Academy of Sciences of the United States of America outline some exciting progress"

Click here to read the full story

In isolation, AUCs for diagnostic caths may miss mark

Appropriate use criteria (AUC) can be useful for decision-making, but is it a hard and fast answer? A prospective study found approximately one-third of patients diagnosed with blocked arteries would have been deemed inappropriate for angiography with 2012 AUCs. Read more here.

Additional PET/CT alters treatment, predicts survival for certain cancer patients

Studies reveal if additional PET/CT could improve cancer management with either radiotherapy or chemoradiotherapy in a large population study set in Taiwan.

Read more.

DOTATATE PET/CT changed treatment plans for 60% of NET patients

PET/CT with Ga-68 DOTATATE has been found to change treatment plans in a majority of patients receiving initial evaluation and subsequent staging of neuroendocrine tumors (NETs), according to the results of two referring physician surveys published Dec. 11 in the Journal of Nuclear Medicine... 

Read the rest of the article here.

Universal's Reconditioning Process

Watch this exciting and comprehensive overview of our partner company, Universal Medical Resources, Inc here.

Neuroimaging in Art

The unorthodox work of one neuroscientist, paintings that depict the micro-structure of the brain, are dazzling to behold. The artist, Greg Dunn, has a PhD in neuroscience and an eye for the finer details of the elements of brain anatomy.

View his stunning artwork here.

Cognitive decline predicted by arterial spin labeling before symptoms appear

Arterial spin labeling (ASL), an MRI technique that doesn’t require contrast, may be able to depict early and subtle alterations in brain perfusion in cognitively normal older patients that can serve as a biomarker of preclinical dementia, according to a study published online in Radiology.

Read more.